[Diseases caused by pharmacological agents in the ENT field].
D045930:Anabolic Agents / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D003638:Deafness / Q000139:chemically induced; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced; D005891:Gingivitis / Q000139:chemically induced; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D007759:Labyrinth Diseases / Q000139:chemically induced; D010038:Otorhinolaryngologic Diseases / Q000139:chemically induced*; D013307:Streptomycin / Q000009:adverse effects
D045930:Anabolic Agents; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000970:Antineoplastic Agents; D006728:Hormones; D006827:Hydantoins; D013307:Streptomycin
Erkrankungen durch Arzneimittel im HNO-Bereich.